Paper Details
- Home
- Paper Details
Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.
Author: HuangS-Q, SuH-H, WangB, WangJ, ZhouS-F
Original Abstract of the Article :
Human cytochrome P450 2C9 (CYP2C9) accounts for approximately 20% of total hepatic CYP content and metabolizes approximately 15% clinically used drugs including S-warfarin, tolbutamide, phenytoin, losartan, diclofenac, and celecoxib. To date, there are at least 33 variants of CYP2C9 (*1B through to ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2174/138920009789895480
データ提供:米国国立医学図書館(NLM)
CYP2C9 Polymorphism: A Genetic Twist on Drug Metabolism
Our bodies are complex chemical factories, and a key part of this intricate machinery is the cytochrome P450 system, a group of enzymes responsible for breaking down drugs and other substances. One particular enzyme, CYP2C9, is crucial for metabolizing a wide range of medications, including warfarin (a blood thinner), certain antidiabetic drugs, and some nonsteroidal anti-inflammatory drugs (NSAIDs).
This research explores the genetic variations in CYP2C9 and how these variations can affect how individuals respond to medications. The researchers found that certain genetic variants, like CYP2C9*2 and CYP2C9*3, can influence the enzyme's activity, leading to variations in drug metabolism. These variations can affect how effective a drug is and even increase the risk of side effects. This study emphasizes the importance of considering individual genetic differences when prescribing medications, particularly those metabolized by CYP2C9.
Tailoring Treatment to the Individual
The findings highlight the significance of personalized medicine, where treatments are tailored to individual genetic profiles. This research provides valuable insights for clinicians in understanding how genetic variations in CYP2C9 can affect drug efficacy and safety.
Navigating the Labyrinth of Drug Metabolism
This research sheds light on the complexity of drug metabolism and the influence of genetic factors. It reminds us that the same drug can have different effects on different individuals, depending on their unique genetic makeup. This knowledge is crucial for optimizing drug therapy and ensuring patient safety.
Dr. Camel's Conclusion
Just like a camel needs to adapt to the harsh desert environment, our bodies need to adapt to different medications. This research reminds us that genetic variations can influence drug metabolism, highlighting the importance of personalized medicine to ensure the best possible outcomes for patients.
Date :
- Date Completed 2010-09-17
- Date Revised 2022-03-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.